Supportive Care in Lung Cancer

2008 ◽  
Vol 24 (1) ◽  
pp. 57-67 ◽  
Author(s):  
Margaret Joyce ◽  
Sue Schwartz ◽  
Maureen Huhmann
Keyword(s):  
Lung Cancer ◽  
Supportive Care

The survival outcomes of patients with lung cancer managed as best supportive care

Lung Cancer ◽  
2021 ◽  
Vol 156 ◽  
pp. S67
Author(s):  
LokYin Cheng ◽  
Ben Walters ◽  
Bravean Kulendrarajah ◽  
Shahul Leyakathali khan
Keyword(s):  
Lung Cancer ◽  
Supportive Care ◽  
Best Supportive Care ◽  
Survival Outcomes

scholarly journals Supportive care in patients with advanced non-small-cell lung cancer

2003 ◽  
Vol 89 (6) ◽  
pp. 1013-1021 ◽  
Author(s):  
M Di Maio ◽  
F Perrone ◽  
C Gallo ◽  
R V Iaffaioli ◽  
L Manzione ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Supportive Care ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals Supportive Care Needs of Patients With Lung Cancer in Mainland China

2019 ◽  
Vol 27 (6) ◽  
pp. e52 ◽  
Author(s):  
Tian ZHANG ◽  
Hongye HE ◽  
Qunhui LIU ◽  
Xiaoqing LV ◽  
Yongxia SONG ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Supportive Care ◽  
Mainland China ◽  
Supportive Care Needs ◽  
Care Needs

Beyond “Second-Line” in Non–Small Cell Lung Cancer: Therapy and Supportive Care

2015 ◽  
pp. e414-e418 ◽  
Author(s):  
Renato G. Martins ◽  
Craig H. Reynolds ◽  
Gregory J. Riely
Keyword(s):  
Lung Cancer ◽  
Palliative Care ◽  
Supportive Care ◽  
Small Cell Lung Cancer ◽  
Cytotoxic Chemotherapy ◽  
Small Cell ◽  
Advanced Lung Cancer ◽  
Care Planning ◽  
Second Line ◽  
Small Cell Lung

Although there once was a single algorithm for the treatment of patients with advanced lung cancer, the modern treatment of advanced lung cancer has multiple treatment pathways that depend on multiple factors, including histology and molecular subtype of disease. New molecular targets, targeted agents, and modes of therapy for patients, including immunotherapy, are being identified at an accelerating pace. These advances are changing outcomes and the treatment landscape, but they also highlight situations with inadequate data to support the use of cytotoxic chemotherapy. In this article, we provide an overview of data regarding cytotoxic chemotherapy and targeted therapy and their value after second line, review the critical role of supportive care and palliative care, and emphasize the importance of advance care planning with our patients. Although this article focuses primarily on NSCLC, the comments about palliative care and advanced care planning also apply to patients with small cell lung cancer.

Sign in / Sign up

Export Citation Format

Share Document